SEARCH

SEARCH BY CITATION

References

  • Altieri M., Di Piero V., Pasquini M., Gasparini M., Vanacore N., Vicenzini E. and Lenzi G. L. (2004) Delayed poststroke dementia: a 4-year follow-up study. Neurology 62, 21932197.
  • Baldwin A. S., Jr (1996) The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu. Rev. Immunol. 14, 649683.
  • Benjannet S., Elagoz A. and Wickham L. et al. (2001) Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J. Biol. Chem. 276, 1087910887.
  • Bennett B. D., Denis P., Haniu M., Teplow D. B., Kahn S., Louis J. C., Citron M. and Vassar R. (2000) A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer’s beta-secretase. J. Biol. Chem. 275, 3771237717.
  • Blasko I., Apochal A., Boeck G., Hartmann T., Grubeck-Loebenstein B. and Ransmayr G. (2001) Ibuprofen decreases cytokine-induced amyloid beta production in neuronal cells. Neurobiol. Dis. 8, 10941101.
  • Bodendorf U., Fischer F., Bodian D., Multhaup G. and Paganetti P. (2001) A splice variant of beta-secretase deficient in the amyloidogenic processing of the amyloid precursor protein. J. Biol. Chem. 276, 1201912023.
  • Bourne K. Z., Ferrari D. C., Lange-Dohna C., Rossner S., Wood T. G. and Perez-Polo J. R. (2007) Differential regulation of BACE1 promoter activity by nuclear factor-kappaB in neurons and glia upon exposure to beta-amyloid peptides. J. Neurosci. Res. 85, 11941204.
  • Buggia-Prevot V., Sevalle J., Rossner S. and Checler F. (2008) NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42. J. Biol. Chem. 283, 1003710047.
  • Capell A., Steiner H., Willem M., Kaiser H., Meyer C., Walter J., Lammich S., Multhaup G. and Haass C. (2000) Maturation and pro-peptide cleavage of beta-secretase. J. Biol. Chem. 275, 3084930854.
  • Charlwood J., Dingwall C. and Matico R. et al. (2001) Characterization of the glycosylation profiles of Alzheimer’s beta -secretase protein Asp-2 expressed in a variety of cell lines. J. Biol. Chem. 276, 1673916748.
  • Chen C. H., Zhou W., Liu S., Deng Y., Cai F., Tone M., Tone Y., Tong Y. and Song W. (2011) Increased NF-kappaB signalling up-regulates BACE1 expression and its therapeutic potential in Alzheimer’s disease. Int. J. Neurophychpharmacol. Published online, doi: 10.1017/S1461145711000149.
  • Cho H. J., Jin S. M., Youn H. D., Huh K. and Mook-Jung I. (2008) Disrupted intracellular calcium regulates BACE1 gene expression via nuclear factor of activated T cells 1 (NFAT 1) signaling. Aging Cell 7, 137147.
  • Cho H. J., Jin S. M., Son S. M., Kim Y. W., Hwang J. Y., Hong H. S. and Mook-Jung I. (2009) Constitutive JAK2/STAT1 activation regulates endogenous BACE1 expression in neurons. Biochem. Biophys. Res. Commun. 386, 175180.
  • Christensen M. A., Zhou W., Qing H., Lehman A., Philipsen S. and Song W. (2004) Transcriptional regulation of BACE1, the beta-amyloid precursor protein beta-secretase, by Sp1. Mol. Cell. Biol. 24, 865874.
  • Creemers J. W., Ines Dominguez D., Plets E., Serneels L., Taylor N. A., Multhaup G., Craessaerts K., Annaert W. and De Strooper B. (2001) Processing of beta-secretase by furin and other members of the proprotein convertase family. J. Biol. Chem. 276, 42114217.
  • Cruts M., Dermaut B., Rademakers R., Roks G., Van den Broeck M., Munteanu G., van Duijn C. M. and Van Broeckhoven C. (2001) Amyloid beta secretase gene (BACE) is neither mutated in nor associated with early-onset Alzheimer’s disease. Neurosci. Lett. 313, 105107.
  • Dunn B. M. (2002) Structure and mechanism of the pepsin-like family of aspartic peptidases. Chem. Rev. 102, 44314458.
  • Ehehalt R., Michel B., De Pietri Tonelli D., Zacchetti D., Simons K. and Keller P. (2002) Splice variants of the beta-site APP-cleaving enzyme BACE1 in human brain and pancreas. Biochem. Biophys. Res. Commun. 293, 3037.
  • Faghihi M. A., Modarresi F. and Khalil A. M. et al. (2008) Expression of a noncoding RNA is elevated in Alzheimer’s disease and drives rapid feed-forward regulation of beta-secretase. Nat. Med. 14, 723730.
  • Fischer F., Molinari M., Bodendorf U. and Paganetti P. (2002) The disulphide bonds in the catalytic domain of BACE are critical but not essential for amyloid precursor protein processing activity. J. Neurochem. 80, 10791088.
  • Fukumoto H., Cheung B. S., Hyman B. T. and Irizarry M. C. (2002) Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch. Neurol. 59, 13811389.
  • Fukumoto H., Rosene D. L., Moss M. B., Raju S., Hyman B. T. and Irizarry M. C. (2004) Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am. J. Pathol. 164, 719725.
  • Ge Y. W., Maloney B., Sambamurti K. and Lahiri D. K. (2004) Functional characterization of the 5′ flanking region of the BACE gene: identification of a 91 bp fragment involved in basal level of BACE promoter expression. FASEB J. 18, 10371039.
  • Glenner G. G. and Wong C. W. (1984a) Alzheimer’s disease and Down’s syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem. Biophys. Res. Commun. 122, 11311135.
  • Glenner G. G. and Wong C. W. (1984b) Alzheimer’s disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem. Biophys. Res. Commun. 120, 885890.
  • Goldgaber D., Lerman M. I., McBride O. W., Saffiotti U. and Gajdusek D. C. (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer’s disease. Science 235, 877880.
  • Gruninger-Leitch F., Schlatter D., Kung E., Nelbock P. and Dobeli H. (2002) Substrate and inhibitor profile of BACE (beta-secretase) and comparison with other mammalian aspartic proteases. J. Biol. Chem. 277, 46874693.
  • Haniu M., Denis P. and Young Y. et al. (2000) Characterization of Alzheimer’s beta -secretase protein BACE. A pepsin family member with unusual properties. J. Biol. Chem. 275, 2109921106.
  • Hebert S. S., Horre K., Nicolai L., Papadopoulou A. S., Mandemakers W., Silahtaroglu A. N., Kauppinen S., Delacourte A. and De Strooper B. (2008) Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer’s disease correlates with increased BACE1/beta-secretase expression. Proc. Natl. Acad. Sci. USA 105, 64156420.
  • Holsinger R. M., McLean C. A., Beyreuther K., Masters C. L. and Evin G. (2002) Increased expression of the amyloid precursor beta-secretase in Alzheimer’s disease. Ann. Neurol. 51, 783786.
  • Hong L., Koelsch G., Lin X., Wu S., Terzyan S., Ghosh A. K., Zhang X. C. and Tang J. (2000) Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science 290, 150153.
  • Huang L. E. and Bunn H. F. (2003) Hypoxia-inducible factor and its biomedical relevance. J. Biol. Chem. 278, 1957519578.
  • Huang L. E., Willmore W. G., Gu J., Goldberg M. A. and Bunn H. F. (1999) Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling. J. Biol. Chem. 274, 90389044.
  • Huse J. T. and Doms R. W. (2000) Closing in on the amyloid cascade: recent insights into the cell biology of Alzheimer’s disease. Mol. Neurobiol. 22, 8198.
  • Huse J. T., Byant D., Yang Y., Pijak D. S., D’Souza I., Lah J. J., Lee V. M., Doms R. W. and Cook D. G. (2003) Endoproteolysis of beta-secretase (beta-site amyloid precursor protein-cleaving enzyme) within its catalytic domain. A potential mechanism for regulation. J. Biol. Chem. 278, 1714117149.
  • Hussain I., Powell D. and Howlett D. R. et al. (1999) Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol. Cell. Neurosci. 14, 419427.
  • Kaltschmidt B., Uherek M., Volk B., Baeuerle P. A. and Kaltschmidt C. (1997) Transcription factor NF-kappaB is activated in primary neurons by amyloid beta peptides and in neurons surrounding early plaques from patients with Alzheimer disease. Proc. Natl. Acad. Sci. USA 94, 26422647.
  • Kang J., Lemaire H. G., Unterbeck A., Salbaum J. M., Masters C. L., Grzeschik K. H., Multhaup G., Beyreuther K. and Muller-Hill B. (1987) The precursor of Alzheimer’s disease amyloid A4 protein resembles a cell-surface receptor. Nature 325, 733736.
  • Koh Y. H., von Arnim C. A., Hyman B. T., Tanzi R. E. and Tesco G. (2005) BACE is degraded via the lysosomal pathway. J. Biol. Chem. 280, 3249932504.
  • Lammich S., Schobel S., Zimmer A. K., Lichtenthaler S. F. and Haass C. (2004) Expression of the Alzheimer protease BACE1 is suppressed via its 5′-untranslated region. EMBO Rep. 5, 620625.
  • Li R., Lindholm K. and Yang L. B. et al. (2004) Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer’s disease patients. Proc. Natl. Acad. Sci. USA 101, 36323637.
  • Li Y., Zhou W., Tong Y., He G. and Song W. (2006) Control of APP processing and Abeta generation level by BACE1 enzymatic activity and transcription. FASEB J. 20, 285292.
  • Lu T., Pan Y., Kao S. Y., Li C., Kohane I., Chan J. and Yankner B. A. (2004) Gene regulation and DNA damage in the ageing human brain. Nature 429, 883891.
  • Marcinkiewicz M. and Seidah N. G. (2000) Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain. J. Neurochem. 75, 21332143.
  • Miyamoto S. and Verma I. M. (1995) Rel/NF-kappa B/I kappa B story. Adv. Cancer Res. 66, 255292.
  • Montine T. J., Markesbery W. R., Morrow J. D. and Roberts L. J., II (1998) Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer’s disease. Ann. Neurol. 44, 410413.
  • Mowrer K. R. and Wolfe M. S. (2008) Promotion of BACE1 mRNA alternative splicing reduces amyloid beta-peptide production. J. Biol. Chem. 283, 1869418701.
  • Mowrer K. R. and Wolfe M. S. (2009) Identification of a cis-acting element involved in the regulation of BACE1 mRNA alternative splicing. J. Neurochem. 109, 10081016.
  • Murphy T., Yip A., Brayne C., Easton D., Evans J. G., Xuereb J., Cairns N., Esiri M. M. and Rubinsztein D. C. (2001) The BACE gene: genomic structure and candidate gene study in late-onset Alzheimer’s disease. Neuroreport 12, 631634.
  • Nelson P. T. and Wang W. X. (2010) MiR-107 is reduced in Alzheimer’s disease brain neocortex: validation study. J. Alzheimers Dis. 21, 7579.
  • Nicolaou M., Song Y. Q. and Sato C. A. et al. (2001) Mutations in the open reading frame of the beta-site APP cleaving enzyme (BACE) locus are not a common cause of Alzheimer’s disease. Neurogenetics 3, 203206.
  • Nourooz-Zadeh J., Liu E. H., Yhlen B., Anggard E. E. and Halliwell B. (1999) F4-isoprostanes as specific marker of docosahexaenoic acid peroxidation in Alzheimer’s disease. J. Neurochem. 72, 734740.
  • Nowak K., Lange-Dohna C., Zeitschel U., Gunther A., Luscher B., Robitzki A., Perez-Polo R. and Rossner S. (2006) The transcription factor Yin Yang 1 is an activator of BACE1 expression. J. Neurochem. 96, 16961707.
  • Nunomura A., Perry G., Pappolla M. A., Wade R., Hirai K., Chiba S. and Smith M. A. (1999) RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease. J. Neurosci. 19, 19591964.
  • O’Connor T., Sadleir K. R. and Maus E. et al. (2008) Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron 60, 9881009.
  • Qing H., Zhou W., Christensen M. A., Sun X., Tong Y. and Song W. (2004) Degradation of BACE by the ubiquitin-proteasome pathway. FASEB J. 18, 15711573.
  • Robakis N. K., Ramakrishna N., Wolfe G. and Wisniewski H. M. (1987) Molecular cloning and characterization of a cDNA encoding the cerebrovascular and the neuritic plaque amyloid peptides. Proc. Natl. Acad. Sci. USA 84, 41904194.
  • Rogers G. W., Jr, Edelman G. M. and Mauro V. P. (2004) Differential utilization of upstream AUGs in the beta-secretase mRNA suggests that a shunting mechanism regulates translation. Proc. Natl. Acad. Sci. USA 101, 27942799.
  • Russo C., Schettini G. and Saido T. C. et al. (2000) Presenilin-1 mutations in Alzheimer’s disease. Nature 405, 531532.
  • Sambamurti K., Kinsey R., Maloney B., Ge Y. W. and Lahiri D. K. (2004) Gene structure and organization of the human beta-secretase (BACE) promoter. FASEB J. 18, 10341036.
  • Sastre M., Dewachter I. and Rossner S. et al. (2006) Nonsteroidal anti-inflammatory drugs repress beta-secretase gene promoter activity by the activation of PPARgamma. Proc. Natl. Acad. Sci. USA 103, 443448.
  • Sayre L. M., Zelasko D. A., Harris P. L., Perry G., Salomon R. G. and Smith M. A. (1997) 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer’s disease. J. Neurochem. 68, 20922097.
  • Schmechel A., Strauss M., Schlicksupp A., Pipkorn R., Haass C., Bayer T. A. and Multhaup G. (2004) Human BACE forms dimers and colocalizes with APP. J. Biol. Chem. 279, 3971039717.
  • Schneider J. A., Wilson R. S., Cochran E. J., Bienias J. L., Arnold S. E., Evans D. A. and Bennett D. A. (2003) Relation of cerebral infarctions to dementia and cognitive function in older persons. Neurology 60, 10821088.
  • Schreck R., Rieber P. and Baeuerle P. A. (1991) Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1. EMBO J. 10, 22472258.
  • Shi X. P., Chen E. and Yin K. C. et al. (2001) The pro domain of beta-secretase does not confer strict zymogen-like properties but does assist proper folding of the protease domain. J. Biol. Chem. 276, 1036610373.
  • Sinha S., Anderson J. P. and Barbour R. et al. (1999) Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature 402, 537540.
  • Smith M. A., Richey Harris P. L., Sayre L. M., Beckman J. S. and Perry G. (1997) Widespread peroxynitrite-mediated damage in Alzheimer’s disease. J. Neurosci. 17, 26532657.
  • Snowdon D. A., Greiner L. H., Mortimer J. A., Riley K. P., Greiner P. A. and Markesbery W. R. (1997) Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 277, 813817.
  • Song W. and Lahiri D. K. (1998a) Functional identification of the promoter of the gene encoding the Rhesus monkey beta-amyloid precursor protein. Gene 217, 165176.
  • Song W. and Lahiri D. K. (1998b) Molecular cloning of the promoter of the gene encoding the Rhesus monkey beta-amyloid precursor protein: structural characterization and a comparative study with other species. Gene 217, 151164.
  • Sun X., Wang Y. and Qing H. et al. (2005) Distinct transcriptional regulation and function of the human BACE2 and BACE1 genes. FASEB J. 19, 739749.
  • Sun X., He G., Qing H., Zhou W., Dobie F., Cai F., Staufenbiel M., Huang L. E. and Song W. (2006a) Hypoxia facilitates Alzheimer’s disease pathogenesis by up-regulating BACE1 gene expression. Proc. Natl. Acad. Sci. USA 103, 1872718732.
  • Sun X., He G. and Song W. (2006b) BACE2, as a novel APP theta-secretase, is not responsible for the pathogenesis of Alzheimer’s disease in Down syndrome. FASEB J. 20, 13691376.
  • Sun X., Tong Y., Qing H., Chen C. H. and Song W. (2006c) Increased BACE1 maturation contributes to the pathogenesis of Alzheimer’s disease in Down syndrome. FASEB J. 20, 13611368.
  • Tanahashi H. and Tabira T. (2001) Three novel alternatively spliced isoforms of the human beta-site amyloid precursor protein cleaving enzyme (BACE) and their effect on amyloid beta-peptide production. Neurosci. Lett. 307, 912.
  • Tanzi R. E., Gusella J. F. and Watkins P. C. et al. (1987) Amyloid beta protein gene: cDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235, 880884.
  • Tesco G., Koh Y. H. and Kang E. L. et al. (2007) Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron 54, 721737.
  • Tong Y., Zhou W., Fung V., Christensen M. A., Qing H., Sun X. and Song W. (2005) Oxidative stress potentiates BACE1 gene expression and Abeta generation. J. Neural Transm. 112, 455469.
  • Vassar R., Bennett B. D. and Babu-Khan S. et al. (1999) Beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735741.
  • Vermeer S. E., Prins N. D., den Heijer T., Hofman A., Koudstaal P. J. and Breteler M. M. (2003) Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 348, 12151222.
  • Walter J., Fluhrer R., Hartung B., Willem M., Kaether C., Capell A., Lammich S., Multhaup G. and Haass C. (2001) Phosphorylation regulates intracellular trafficking of beta-secretase. J. Biol. Chem. 276, 1463414641.
  • Wang W. X., Rajeev B. W., Stromberg A. J., Ren N., Tang G., Huang Q., Rigoutsos I. and Nelson P. T. (2008) The expression of microRNA miR-107 decreases early in Alzheimer’s disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. J. Neurosci. 28, 12131223.
  • Weggen S., Eriksen J. L. and Das P. et al. (2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414, 212216.
  • Wen Y., Yu W. H. and Maloney B. et al. (2008) Transcriptional regulation of beta-secretase by p25/cdk5 leads to enhanced amyloidogenic processing. Neuron 57, 680690.
  • Westmeyer G. G., Willem M., Lichtenthaler S. F., Lurman G., Multhaup G., Assfalg-Machleidt I., Reiss K., Saftig P. and Haass C. (2004) Dimerization of beta-site beta-amyloid precursor protein-cleaving enzyme. J. Biol. Chem. 279, 5320553212.
  • White L., Petrovitch H., Hardman J., Nelson J., Davis D. G., Ross G. W., Masaki K., Launer L. and Markesbery W. R. (2002) Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Ann. N Y Acad. Sci. 977, 923.
  • Xue S., Jia L. and Jia J. (2006) Hypoxia and reoxygenation increased BACE1 mRNA and protein levels in human neuroblastoma SH-SY5Y cells. Neurosci. Lett. 405, 231235.
  • Yan R., Bienkowski M. J. and Shuck M. E. et al. (1999) Membrane-anchored aspartyl protease with Alzheimer’s disease beta-secretase activity. Nature 402, 533537.
  • Yang L. B., Lindholm K. and Yan R. et al. (2003) Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat. Med. 9, 34.
  • Zhang X., Zhou K., Wang R., Cui J., Lipton S. A., Liao F. F., Xu H. and Zhang Y. W. (2007) Hypoxia-inducible factor 1alpha (HIF-1alpha)-mediated hypoxia increases BACE1 expression and beta-amyloid generation. J. Biol. Chem. 282, 1087310880.
  • Zhao J., Fu Y. and Yasvoina M. et al. (2007) Beta-site amyloid precursor protein cleaving enzyme 1 levels become elevated in neurons around amyloid plaques: implications for Alzheimer’s disease pathogenesis. J. Neurosci. 27, 36393649.
  • Zhou W. and Song W. (2006) Leaky scanning and reinitiation regulate BACE1 gene expression. Mol. Cell. Biol. 26, 33533364.
  • Zhou W., Cai F., Li Y., Yang G. S., O’Connor K. D., Holt R. A. and Song W. (2010) BACE1 gene promoter single-nucleotide polymorphisms in Alzheimer’s disease. J. Mol. Neurosci. 42, 127133.
  • Zohar O., Cavallaro S., D’Agata V. and Alkon D. L. (2003) Quantification and distribution of beta-secretase alternative splice variants in the rat and human brain. Brain Res. Mol. Brain Res. 115, 6368.